rs58679007

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001004356.3(FGFRL1):​c.828G>A​(p.Pro276Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00229 in 1,612,622 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 32 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 40 hom. )

Consequence

FGFRL1
NM_001004356.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -4.57

Publications

4 publications found
Variant links:
Genes affected
FGFRL1 (HGNC:3693): (fibroblast growth factor receptor like 1) The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. A marked difference between this gene product and the other family members is its lack of a cytoplasmic tyrosine kinase domain. The result is a transmembrane receptor that could interact with other family members and potentially inhibit signaling. Multiple alternatively spliced transcript variants encoding the same isoform have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 4-1024420-G-A is Benign according to our data. Variant chr4-1024420-G-A is described in ClinVar as Benign. ClinVar VariationId is 787268.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.57 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0104 (1584/152298) while in subpopulation AFR AF = 0.0349 (1452/41564). AF 95% confidence interval is 0.0334. There are 32 homozygotes in GnomAd4. There are 728 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 32 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGFRL1NM_001004356.3 linkc.828G>A p.Pro276Pro synonymous_variant Exon 6 of 7 ENST00000510644.6 NP_001004356.1 Q8N441A0PJ49

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGFRL1ENST00000510644.6 linkc.828G>A p.Pro276Pro synonymous_variant Exon 6 of 7 1 NM_001004356.3 ENSP00000425025.1 Q8N441
FGFRL1ENST00000264748.6 linkc.828G>A p.Pro276Pro synonymous_variant Exon 5 of 6 1 ENSP00000264748.6 Q8N441
FGFRL1ENST00000504138.5 linkc.828G>A p.Pro276Pro synonymous_variant Exon 6 of 7 1 ENSP00000423091.1 Q8N441
FGFRL1ENST00000398484.6 linkc.828G>A p.Pro276Pro synonymous_variant Exon 7 of 8 5 ENSP00000381498.2 Q8N441

Frequencies

GnomAD3 genomes
AF:
0.0104
AC:
1586
AN:
152180
Hom.:
32
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0350
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00530
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00310
AC:
768
AN:
247458
AF XY:
0.00224
show subpopulations
Gnomad AFR exome
AF:
0.0357
Gnomad AMR exome
AF:
0.00331
Gnomad ASJ exome
AF:
0.00121
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000927
Gnomad NFE exome
AF:
0.000397
Gnomad OTH exome
AF:
0.00347
GnomAD4 exome
AF:
0.00144
AC:
2103
AN:
1460324
Hom.:
40
Cov.:
33
AF XY:
0.00126
AC XY:
914
AN XY:
726476
show subpopulations
African (AFR)
AF:
0.0408
AC:
1366
AN:
33476
American (AMR)
AF:
0.00385
AC:
172
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00103
AC:
27
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86250
European-Finnish (FIN)
AF:
0.000115
AC:
6
AN:
52098
Middle Eastern (MID)
AF:
0.00312
AC:
18
AN:
5764
European-Non Finnish (NFE)
AF:
0.000253
AC:
281
AN:
1111872
Other (OTH)
AF:
0.00361
AC:
218
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
138
275
413
550
688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0104
AC:
1584
AN:
152298
Hom.:
32
Cov.:
32
AF XY:
0.00978
AC XY:
728
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0349
AC:
1452
AN:
41564
American (AMR)
AF:
0.00529
AC:
81
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000324
AC:
22
AN:
67998
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
85
170
255
340
425
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00538
Hom.:
15
Bravo
AF:
0.0126
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FGFRL1-related disorder Benign:1
Feb 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.45
DANN
Benign
0.93
PhyloP100
-4.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58679007; hg19: chr4-1018208; API